% | $
Quotes you view appear here for quick access.

ONYX Pharmaceuticals, AŞ Message Board

  • johnpapas893 johnpapas893 Aug 12, 2013 7:59 PM Flag

    Onyx Pharmaceuticals Downgraded by Leerink Swann to “Market Perform” (ONXX)

    Onyx Pharmaceuticals (NASDAQ:ONXX) was downgraded by analysts at Leerink Swann from an “outperform” rating to a “market perform” rating in a research report issued to clients and investors on Monday.
    The analysts noted that the move was a valuation call. Valuation call, based on a $140 price target, Leerink Swann said.